Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.smaller Cos. Regulatory News (BSV)

Share Price Information for Br.smaller Cos. (BSV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 80.00
Bid: 78.50
Ask: 81.50
Change: 0.00 (0.00%)
Spread: 3.00 (3.822%)
Open: 80.00
High: 80.00
Low: 80.00
Prev. Close: 80.00
BSV Live PriceLast checked at -
British Smaller Companies VCT is an Investment Trust

To maximise Total Return and provide investors with an attractive long-term tax-free dividend yield while maintaining the Company's status as a venture capital trust.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

3rd Quarter Results

15 Mar 2024 12:15

RNS Number : 0800H
British Smaller Companies VCT PLC
15 March 2024
 

British Smaller Companies VCT plc

Interim Management Statement

For the quarter ended 31 December 2023

British Smaller Companies VCT plc (the "Company") presents its interim management statement for the quarter ended 31 December 2023. The statement also includes relevant financial information between the end of the quarter and the date of this statement. A copy of this interim management statement can be found at www.bscfunds.com.

Overview

In the quarter to 31 December 2023, the Company's Net Asset Value per share was up by 3.3 pence, or 4.0 per cent of the opening NAV, prior to the payment of the interim dividend of 2.0 pence on 8 December 2023. The FTSE Small Cap Index rose by 5.4 per cent during the period.

The Company's Total Return at 31 December 2023 was up 3.3 pence, to 262.6 pence per ordinary share.

During the quarter, the Company invested a further £0.8 million into Force24 and £0.5 million into Vuealta. Subsequent to the quarter end, the Company has invested £1.8 million into three follow on investments; Outpost, Relative Insight and SharpCloud.

In November 2023 the Company exited its investment in E2E for £2.0 million, representing a 2.5x return on the Company's cost. Also in November, the investment in MacroArt was realised for £1.5 million, representing a 2.0x return on cost for the Company. 

The Company has seen further realisations post-quarter-end, partially realising its investments in KeTech and Arcus in January 2024, and fully exiting its investment in Displayplan in February 2024, all at valuations in line with fair value at 31 December 2023.

To maximise shareholder value, the KeTech business was split into its two component parts, Rail and Defence. The Defence business subsequently sold in January 2024, generating proceeds of £1.5 million. To date, the Company has realised proceeds of £4.1 million from its KeTech investment, a 2.0x return on cost, while still retaining its investment in the Rail Business, which at the period end was valued at £1.3 million.

In February 2024, the Company sold its investment in Displayplan for £9.0 million. Total proceeds received over the life of the investment are £12.5 million, an excellent 9.6x return on the Company's cost. There is the potential for further deferred proceeds in due course. 

Performance

The table below sets out movements in key metrics for the Company. 

 

 

30 September 2023

Increase in Value

Shares issued/dividend paid

Buyback of shares

Movement

In Period

31 December 2023

Net Assets (£m)

198.6

7.8

(3.8)

(0.8)

3.2

201.8

NAV per share (PPS)

82.4

3.3

(2.0)

-

1.3

83.7

Cumulative dividends paid (PPS)

176.9

-

2.0

-

2.0

178.9

Total Return (PPS)

259.3

3.3

-

-

3.3

262.6

Shares in issue

240,991,484

-

1,220,008

(975,567)

244,441

241,235,925

Cumulative dividends paid at 31 December 2023 were 178.9 pence per ordinary share (30 September 2023: 176.9 pence per ordinary share) following the interim dividend of 2.0 pence paid on 8 December 2023.

The movements in NAV and NAV per ordinary share are set out in the table below:

 

 

£m

Pence per

ordinary share

NAV at 30 September 2023

198.6

82.4

Increase in portfolio value

7.6

3.2

Net operating income

0.2

0.1

7.8

3.3

Issue/buy-back of shares

0.2

-

Total Return in the period

8.0

3.3

NAV before dividends

206.6

85.7

Dividends paid

(4.8)

(2.0)

NAV at 31 December 2023

 

201.8

 

83.7

 

Dividends and shares in issue

On 8 December 2023 the Company issued 1,220,008 shares under the Company's Dividend Re-investment Scheme (DRIS).

Under its standing buyback authority, on 18 December 2023 the Company purchased 975,567 shares at 76.88 pence per share at a cost of £0.8 million. These shares are held in treasury. 

On 30 January 2024 the Company issued 22,560,594 shares in relation to its 2023/24 fundraising, following which the Company's issued share capital consists of 263,796,519 ordinary shares with voting rights and 24,501,263 shares held in treasury.

Net assets

Net assets at 31 December 2023 comprised the following:

£000

% of net assets

Unquoted investments at fair value

135,649

67.2

Cash and money market funds

63,490

31.5

Other net assets

2,655

1.3

Net assets

201,794

100.0

Investments

The investment portfolio at 31 December 2023 comprised:

Valuation

£000

Cumulative valuation as a % of net assets

Matillion

26,440

13.1%

Unbiased

12,545

19.3%

Outpost

8,819

23.7%

Displayplan

8,806

28.1%

Elucidat

6,596

31.3%

Force24

6,189

34.4%

Wooshii

5,457

37.1%

SharpCloud

4,965

39.6%

Vypr

4,834

41.9%

ACC Aviation

4,340

44.1%

88,991

44.1%

Other investments

46,658

67.2%

Total investments

135,649

67.2%

Portfolio performance

Over the quarter to 31 December 2023, the aggregate unquoted portfolio valuation has increased by £7.6 million.

Fundraising

The Company announced a new share offer on 20 September 2023, alongside British Smaller Companies VCT2 plc, with the intention of raising up to £90 million, in aggregate, which included an over-allotment facility of £25 million, in aggregate. The offers closed to new Applications on 16 February 2024. Gross Applications of £90 million have been received, of which c.£55.5 million relate to the Company. The first allotment of £30 million (£18.6 million relating to the Company) took place on 30 January 2024; the second and final allotment will take place in early April 2024.

Outlook

In the last quarter of the year, there was a notable upturn in the economic forecast. We witnessed a decline in inflation rates and a growing consensus that interest rates might be lowered in 2024. Nevertheless, we're keeping a close eye on any potential shifts, particularly given recent instability in the Middle East, which have raised concerns about a resurgence in input costs. Additionally, upcoming elections in both the UK and US in 2024 may influence the economic outlook.

The portfolio has demonstrated robust revenue growth in an efficient manner through a tough trading period, which should leave portfolio companies well positioned to continue their positive trajectory as the economic environment improves. Moreover, the close of the Company's 2023/24 fundraising in February positions the Company strongly to continue supporting the portfolio and to invest further in new opportunities in the year ahead.

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU No. 596/2014). Upon the publication of this announcement via Regulatory Information Service this inside information is now considered to be in the public domain.

15 March 2024

For further information please contact:

David Hall YFM Private Equity Limited Tel: 0113 244 1000

Alex Collins Panmure Gordon (UK) Limited Tel: 0207 886 2767

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRTEAFDSFSKLEFA
Date   Source Headline
15th Feb 20199:58 amRNSPayment of dividend and Allotment of shares
11th Feb 201911:15 amRNSClose of Offers to New Applications
11th Feb 201911:15 amRNSClose of Offers to New Applications
28th Jan 20193:00 pmRNSUtilisation of over-allotment facility
28th Jan 20193:00 pmRNSUtilisation of over-allotment facility
7th Jan 20192:15 pmRNSDividend Declaration
7th Jan 20191:15 pmRNSStatement re Prospectus
7th Jan 20191:15 pmRNSStatement re Prospectus
7th Jan 201911:32 amRNSResult of Meeting
21st Dec 20189:10 amRNSDisposal
20th Dec 201810:18 amRNSTransaction in Own Shares
27th Nov 20186:07 pmRNSPublication of Prospectus
27th Nov 20186:07 pmRNSCircular re Incentive Scheme
27th Nov 20185:49 pmRNSPublication of Prospectus
21st Nov 20181:00 pmRNSHalf-year Report to 30 September 2018
23rd Oct 20181:00 pmRNSStatement re proposed joint fundraising
23rd Oct 20181:00 pmRNSStatement re proposed joint fundraising
27th Sep 20181:24 pmRNSTransaction in Own Shares
20th Sep 20183:03 pmRNSDirector/PDMR Shareholding
5th Sep 20182:56 pmRNSAGM Statement
17th Aug 20188:25 amRNSInterim Management Statement
4th Jul 20184:56 pmRNSTransaction in Own Shares
26th Jun 20181:26 pmRNSAnnual Financial Report
18th May 201810:15 amRNSPayment of interim dividend and issue of shares
12th Apr 20188:06 amRNSDividend Declaration
28th Mar 20188:33 amRNSTransaction in Own Shares
2nd Mar 20187:12 amRNSTransaction in Own Shares
26th Feb 20181:51 pmRNSTransaction in Own Shares
23rd Feb 20189:06 amRNSInterim Management Statement
20th Dec 20178:50 amRNSPurchase of own securities and total voting rights
1st Dec 20179:14 amRNSHalf-year Report
28th Sep 20172:59 pmRNSTransaction in Own Shares
23rd Aug 20176:15 pmRNSInterim Management Statement
3rd Aug 20172:04 pmRNSAppointment of non-executive director
2nd Aug 20178:04 amRNSResult of Annual General Meeting
16th Jun 20171:20 pmRNSAnnual Financial Report Announcement
26th May 201711:26 amRNSPayment of Interim Dividend and Issue of Shares
26th Apr 20179:29 amRNSDividend Declaration
30th Mar 20179:14 amRNSPurchase of Own Securities and Total Voting Rights
29th Mar 201711:22 amRNSIssue of Equity and Close of Offer
6th Mar 20173:43 pmRNSClose of Offer to New Subscriptions
28th Feb 201710:17 amRNSStatement re Offer for Subscription
10th Feb 201711:54 amRNSInterim Management Statement & Launch of Offer
18th Jan 201710:04 amRNSPayment of Dividend and Allotment of Shares
6th Dec 201610:03 amRNSHalf-year Report
28th Nov 20167:04 amRNSDisposal
5th Aug 20169:55 amRNSPayment of dividends and allotment of shares
28th Jul 20168:56 amRNSInterim Management Statement
27th Jul 20163:02 pmRNSResult of AGM
8th Jul 201611:27 amRNSCompletion of new investment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.